DUBLIN--(BUSINESS WIRE)--The "Viral Vectors & Plasmid DNA Manufacturing Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering. Overall world revenue for the viral vectors ...
Bionova Scientific LLC, an Asahi Kasei company and a bespoke contract development and manufacturing organization (CDMO), announced a strategic manufacturing alliance with Syenex, a genetic medicines ...
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) and Captain T Cell, a spinoff from the renowned Max Delbrück Center Berlin, Germany, today announced a ...
Austin, Texas, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Viral Vectors and Plasmid DNA Manufacturing Market Size & Growth Analysis: According to SNS Insider, the Viral Vectors and Plasmid DNA Manufacturing ...
Under the agreement, Bionova will serve as the preferred manufacturing partner for Syenex’s best-in-class delivery platforms.
MILAN, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer Company in immuno-oncology, and ANEMOCYTE, a leading provider of advanced therapy and nucleic acids solutions, today ...
End-to-End Manufacturing at a Single Site and High-throughput Vector Suite Design Will Bolster Batch Production Up to Five Times KING OF PRUSSIA, Pa., Dec. 8, 2022 /PRNewswire/ -- The Center for ...
CDMO ProBio, the biologics subsidiary of GenScript, expanded its plasmid DNA and viral vector production capacity with the opening of new manufacturing facility in Hopewell, New Jersey. The site, ...
DNA vaccines, wherein a new antigen is inserted into a validated vector, have tremendous potential for deployment in pandemic applications as they can be rapidly produced in a validated, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback